Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory D Lewis

Showing results (181-190 of 270) with videos related to

Pageof 27
Sort By:
Journal of the American College of Cardiology|April 10, 2024
Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic CardiomyopathyJames L Januzzi, Javed Butler, Stefano Del Prato, et al.
American Journal of Medical Genetics. Part A|June 13, 2015
Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double-blind, pilot studyBarbara K Burton, Kenneth I Berger, Gregory D Lewis, et al.
Circulation|May 22, 2015
Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot StudyYonathan F Melman, Ravi Shah, Kirsty Danielson, et al.
European Heart Journal|August 26, 2021
Physical activity and fitness in the community: the Framingham Heart StudyMatthew Nayor, Ariel Chernofsky, Nicole L Spartano, et al.
Nature Biotechnology|June 21, 2011
A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular diseaseTerri A Addona, Xu Shi, Hasmik Keshishian, et al.
Journal of Cardiac Failure|July 19, 2023
Systemic Arterial Oxygen Levels Differentiate Pre- and Post-capillary Predominant Hemodynamic Abnormalities During Exercise in Undifferentiated Dyspnea on ExertionKathryn M Hardin, Ilya Giverts, Joseph Campain, et al.
American Heart Journal|November 13, 2022
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathyJames L Januzzi, Javed Butler, Stefano Del Prato, et al.
JACC. Heart Failure|October 25, 2025
Functional and Prognostic Implications of Different Iron Deficiency Definitions in Heart Failure: Insights From HEART-FIDGregory D Lewis, Anna Giczewska, Robert J Mentz, et al.
JACC. Heart Failure|June 11, 2025
Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in HFpEFSujin Lee, Nicholas E Houstis, Thomas F Cunningham, et al.
Circulation|February 10, 2016
Response to Letter Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study"Yonathan F Melman, Ravi Shah, Kirsty Danielson, et al.
Pageof 27

Showing results (181-190 of 270) with videos related to

Sort By:
Pageof 27
Journal of the American College of Cardiology|April 10, 2024
Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic CardiomyopathyJames L Januzzi, Javed Butler, Stefano Del Prato, et al.
American Journal of Medical Genetics. Part A|June 13, 2015
Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double-blind, pilot studyBarbara K Burton, Kenneth I Berger, Gregory D Lewis, et al.
Circulation|May 22, 2015
Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot StudyYonathan F Melman, Ravi Shah, Kirsty Danielson, et al.
European Heart Journal|August 26, 2021
Physical activity and fitness in the community: the Framingham Heart StudyMatthew Nayor, Ariel Chernofsky, Nicole L Spartano, et al.
Nature Biotechnology|June 21, 2011
A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular diseaseTerri A Addona, Xu Shi, Hasmik Keshishian, et al.
Journal of Cardiac Failure|July 19, 2023
Systemic Arterial Oxygen Levels Differentiate Pre- and Post-capillary Predominant Hemodynamic Abnormalities During Exercise in Undifferentiated Dyspnea on ExertionKathryn M Hardin, Ilya Giverts, Joseph Campain, et al.
American Heart Journal|November 13, 2022
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathyJames L Januzzi, Javed Butler, Stefano Del Prato, et al.
JACC. Heart Failure|October 25, 2025
Functional and Prognostic Implications of Different Iron Deficiency Definitions in Heart Failure: Insights From HEART-FIDGregory D Lewis, Anna Giczewska, Robert J Mentz, et al.
JACC. Heart Failure|June 11, 2025
Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in HFpEFSujin Lee, Nicholas E Houstis, Thomas F Cunningham, et al.
Circulation|February 10, 2016
Response to Letter Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study"Yonathan F Melman, Ravi Shah, Kirsty Danielson, et al.
Pageof 27